Medications not yet evaluated by P&T are considered NON-FORMULARY. Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step!
Please be sure to document all clinical activities daily.
Search results for:

nelarabine

nelarabine
  • Restricted Arranon --> Restricted to Outpatient Medical ~OR~ Approval by pharmacy admin for inpatient.
  • Restricted Anti-Neoplastic Formulary
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Arranon SOLUTION, INTRAVENOUS 5 mg/mL      
Comments:

Is indicated for T-cell lymphoblastic leukemia and lymphoma after failure of other treatments. Rare use is expected and will mainly be given in the outpatient setting. May be evaluated on an individual basis for inpatient use - contact pharmacy management.

Last updated: Mar. 5, 2025
Rhazdrugs nelarabine






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2026 Rpharmy, LLC ­ All Rights Reserved